Posted on 06 September 2010 by admin
 |
Hello Fellow Traders,
We hope everyone is enjoying the long Holiday Weekend. As promised in our earlier Monster Stock Alerts, we are bringing you more research on our Monster Pick for this week, RMCP. See what the experts are saying about the necessity of the company's product :
- "Unsafe injection practices are one of the leading causes of infections in doctors' offices"
-Center For Disease Control - "99 percent of all fifth-year medical/surgical residents had suffered multiple injuries"
-New England Journal of Medicine - "The CDC estimates more than 80 percent of needlestick injuries can be prevented by the use of safer medical devices, such as the RMCP safety syringe"
Recent Company Highlights:
- FDA clearance for its RevVac safety syringe
- $1.6 Bill safety syringe market
- The world's least expensive and best automatic safety syringe
- Significant global interest in their revolutionary product release
- Received 2010 Medical Design Excellence Award
- Signed Letter of Intent with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. (5 million syringes per month)
- CEO Ron Wheet is scheduled to do an interview on Thursday, September 9th at 11:00AM EDT with www.wallstreetreporter.com. Everyone can access this interview by logging onto their website and clicking on the link next to our name.
- Barchart.com continues to rate RMCP a STRONG BUY!!
|
RMCP also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images. So the company is no one trick pony.
Our Monster Pick this week, Revolutions Medical Corp. (OTC:RMCP), Friday traded up 0.16 (26.95%) to close at 0.75. Then, after market, announced signing a Letter of Intent with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe.
The agreed upon general terms provide for the manufacturing of 5 million syringes per month and can allow an increase of up to 20 million syringes per month. MIG has both domestic and international manufacturing capabilities.
Can RMCP follow up announcements of large orders be far behind and manufacturing Letter of Intent and CEO Ron Wheet's scheduled interview on Thursday, September 9th? We think not.
Our Monster Stock Pick this week : RMCP - STRONG BUY
- "Happy Trading" |
|
 |
|
If you'd like to unsubscribe and stop receiving these emails
click here.